Shares of Afya Limited (NASDAQ:AFYA – Get Free Report) have earned a consensus rating of “Hold” from the seven ratings firms that are presently covering the firm, MarketBeat reports. One analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a buy rating to the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $17.3750.
A number of analysts have issued reports on AFYA shares. Wall Street Zen upgraded shares of Afya from a “buy” rating to a “strong-buy” rating in a report on Saturday, January 10th. Sanford C. Bernstein upgraded Afya to a “market perform” rating in a research report on Friday. JPMorgan Chase & Co. reissued a “neutral” rating and set a $22.00 price target (down from $24.50) on shares of Afya in a research note on Wednesday, January 7th. Weiss Ratings reissued a “hold (c)” rating on shares of Afya in a research note on Wednesday, October 8th. Finally, UBS Group reiterated a “neutral” rating and issued a $16.00 target price (down previously from $18.00) on shares of Afya in a report on Friday.
Check Out Our Latest Stock Analysis on Afya
Afya Price Performance
Institutional Investors Weigh In On Afya
A number of hedge funds have recently made changes to their positions in the stock. Militia Capital Partners LP purchased a new stake in shares of Afya during the 2nd quarter valued at $71,000. Quantbot Technologies LP purchased a new position in shares of Afya in the second quarter worth $117,000. Van ECK Associates Corp grew its stake in Afya by 15.7% during the 3rd quarter. Van ECK Associates Corp now owns 10,170 shares of the company’s stock valued at $159,000 after purchasing an additional 1,377 shares during the last quarter. State of Wyoming acquired a new position in Afya in the 2nd quarter worth approximately $164,000. Finally, Quadrature Capital Ltd purchased a new position in Afya during the 2nd quarter worth approximately $181,000. 88.02% of the stock is currently owned by hedge funds and other institutional investors.
About Afya
Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.
At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.
Recommended Stories
- Five stocks we like better than Afya
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- URGENT: Trump Just Triggered AI’s Biggest Disruption Yet
- Wall Street Alert: Buy AES
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.
